The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Gentiva Health Services, Inc. (“Gentiva” or the “Company”) (NASDAQ: GTIV) relating to the proposed buyout of the Company by Kindred Healthcare, Inc. (“Kindred”).

On October 9, 2014, Gentiva and Kindred announced the signing of a definitive merger agreement pursuant to which Kindred will acquire Gentiva in a transaction valued at approximately $1.8 billion.

Under the terms of the transaction, Gentiva shareholders are anticipated to receive $14.50 per share in cash and $5.00 of Kindred common stock (which equates to 0.257 shares of Kindred common stock based upon an agreed upon fixed exchange ratio), for each share of Gentiva they own. The transaction is expected to close in the first quarter of 2015, though Gentiva shareholders will most likely be asked to vote on the transaction well before that time.

The firm’s investigation seeks to determine, among other things, whether Gentiva’s Board of Directors failed to satisfy their duties to the Company’s shareholders, including whether the board adequately pursued alternatives to the acquisition and whether the board obtained the best price possible for the Company’s shares of common stock. In particular, according to Yahoo! Finance, at least one Wall Street analyst has issued a price target for Gentiva stock at $20.00 per share.

If you currently own common stock of Gentiva and would like to learn more about the investigation being conducted by Brower Piven, without cost or obligation to you, please visit our website at You may also request more information by contacting Brower Piven either by email at or by telephone at (410) 415-6616.

Attorneys at Brower Piven have extensive experience in litigating securities and other class action cases and have been advocating for the rights of shareholders since the 1980s.

Copyright Business Wire 2010